Synthos invests $2M in Global Bioenenergies and butadiene process

In France, Global Bioenergies announced a deal with Poland-based Synthos to develop a new process for the conversion of renewable resources into butadiene, involving research funding, multi-million euro development fees, royalty payments, repartition of exploitation rights, and a $2 million equity investment in Global Bioenergies.

Both parties have different responsibilities in the project, with Global Bioenergies taking care of research and process development at the laboratory level, and Synthos subsequently taking the process on to the industrialization stage.